THE SIGNIFICANCE OF PRE-SCREENING OF SUBCLINICAL MALIGNANCIES BEFORE THE TREATMENT OF BIOLOGIC AGENTS OR JAK INHIBITORS TO CONNECTIVE TISSUE DISEASE PATIENTS.

Details

Language :

English

ISSN :

00034967

Volume :

82

Database :

Complementary Index

Journal :

Annals of the Rheumatic Diseases

Publication Type :

Academic Journal

Accession number :

164385395

Full Text :

https://doi.org/10.1136/annrheumdis-2023-eular.4307